GeneDx Holdings Corp. is 1.4x more valuable than Pennant Group, Inc. by market capitalization ($1.61 B vs $1.12 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PNTG | WGS |
|---|---|---|
| Market cap | $1.12 B | $1.61 B |
| US-listed rank | #2553 | #2258 |
| Revenue (latest FY) | $947.71M | $427.54M |
| Net income (latest FY) | $29.58M | -$21.00M |
| Net margin | 3.1% | -4.9% |
| P/E (trailing FY) | 38.0 | - |
| SEC filings | 500 | 748 |
GeneDx Holdings Corp. is 1.4x more valuable than Pennant Group, Inc. by market capitalization ($1.61 B vs $1.12 B).
In their latest fiscal years, Pennant Group, Inc. reported $947.71M in revenue while GeneDx Holdings Corp. reported $427.54M.
Full pages: Pennant Group, Inc. and GeneDx Holdings Corp., or browse the full rankings.